Development of Highly Selective Kv1.3-Blocking Peptides Based on the Sea Anemone Peptide ShK
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
ShK, from the sea anemone Stichodactyla helianthus, is a 35-residue disulfide-rich peptide that blocks the voltage-gated potassium channel Kv1.3 at ca. 10 pM and the related channel Kv1.1 at ca. 16 pM. We developed an analog of this peptide, ShK-186, which is currently in Phase 1b-2a clinical trials for the treatment of autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. While ShK-186 displays a >100-fold improvement in selectivity for Kv1.3 over Kv1.1 compared with ShK, there is considerable interest in developing peptides with an even greater selectivity ratio. In this report, we describe several variants of ShK that incorporate p-phophono-phenylalanine at the N-terminus coupled with internal substitutions at Gln16 and Met21. In addition, we also explored the combinatorial effects of these internal substitutions with an alanine extension at the C-terminus. Their selectivity was determined by patch-clamp electrophysiology on Kv1.3 and Kv1.1 channels stably expressed in mouse fibroblasts. The peptides with an alanine extension blocked Kv1.3 at low pM concentrations and exhibited up to 2250-fold selectivity for Kv1.3 over Kv1.1. Analogs that incorporates p-phosphono-phenylalanine at the N-terminus blocked Kv1.3 with IC50s in the low pM range and did not affect Kv1.1 at concentrations up to 100 nM, displaying a selectivity enhancement of >10,000-fold for Kv1.3 over Kv1.1. Other potentially important Kv channels such as Kv1.4 and Kv1.6 were only partially blocked at 100 nM concentrations of each of the ShK analogs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The IC50 of ShK-223 for Kv1.3 channels is 25 ± 14 pM, > 10,000 times more selective for Kv1.3 channels as compared to neuronal Kv1.1 and Kv1.2 channels [25].”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis?
DeCoursey, T. E., Chandy, K. G., Gupta, S., & Cahalan, M. D. (1984) · Nature · doi:10.1038/307465a0 · Cited by 744 · cited 1×
“3 channel was discovered in the early 1980’s by the Chandy and Cahalan labs at the University of California Irvine [19] and the Deutsch lab at the University of Pennsylvania [20].”
BackgroundKv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
Beeton, C., Wulff, H., Standifer, N. E., Azam, P., Mullen, K. M., Pennington, M. W., Kolski-Andreaco, A., Wei, E., Grino, A., Counts, D. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605136103 · Cited by 538
Self-citationThe voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS
Wulff, H., Calabresi, P. A., Allie, R., Yun, S., Pennington, M., Beeton, C., & Chandy, K. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16921 · Cited by 422
Self-citationOn the Convergent Evolution of Animal Toxins
Dauplais, M., Lecoq, A., Song, J., Cotton, J., Jamin, N., Gilquin, B., Roumestand, C., Vita, C., de Medeiros, C. C., Rowan, E. G., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4302 · Cited by 336 · cited 2×
“6 Å from the planar aromatic ring of the Tyr23 residue, a juxtaposition that led to the description of this pairing as a functional diad [14].”
BackgroundBeeton, C., Wulff, H., Barbaria, J., Clot-Faybesse, O., Pennington, M., Bernard, D., Cahalan, M. D., Chandy, K. G., & Béraud, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241497298 · Cited by 318
Self-citationK channels in T lymphocytes: a patch clamp study using monoclonal antibody adhesion
Matteson, D. R., & Deutsch, C. (1984) · Nature · doi:10.1038/307468a0 · Cited by 314 · cited 1×
“3 channel was discovered in the early 1980’s by the Chandy and Cahalan labs at the University of California Irvine [19] and the Deutsch lab at the University of Pennsylvania [20].”
BackgroundCastañeda, O., Sotolongo, V., Amor, A. M., Stöcklin, R., Anderson, A. J., Harvey, A. L., Engström, Å., Wernstedt, C., & Karlsson, E. (1995) · Toxicon · doi:10.1016/0041-0101(95)00013-c · Cited by 283 · cited 1×
“This 35-residue peptide, ShK toxin, also contained three disulfide bonds but was the first peptide toxin from a sea anemone that blocked K channels [6].”
BackgroundShK-Dap22, a Potent Kv1.3-specific Immunosuppressive Polypeptide
Kalman, K., Pennington, M. W., Lanigan, M. D., Nguyen, A., Rauer, H., Mahnir, V., Paschetto, K., Kem, W. R., Grissmer, S., Gutman, G. A., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32697 · Cited by 256 · cited 1×
“3 ever described, with an IC50 by patch-clamp of 10 pM [15] and equilibrium binding to Kv1.”
BackgroundSelf-citationBeeton, C., Pennington, M. W., Wulff, H., Singh, S., Nugent, D., Crossley, G., Khaytin, I., Calabresi, P. A., Chen, C.-Y., Gutman, G. A., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008193 · Cited by 249 · cited 2×
“Other non-hydrolysable analogs of the N-terminal pTyr, such as para phosphonphenylalanine (Ppa), have also been prepared, with and without substitutions of Met21 (ShK-190) with the nonoxidizable Nle residue (ShK-192) [28,32].”
BackgroundSelf-citationSea Anemone (Cnidaria, Anthozoa, Actiniaria) Toxins: An Overview
Frazão, B., Vasconcelos, V., & Antunes, A. (2012) · Marine Drugs · doi:10.3390/md10081812 · Cited by 223
Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases
Chi, V., Pennington, M. W., Norton, R. S., Tarcha, E. J., Londono, L. M., Sims-Fahey, B., Upadhyay, S. K., Lakey, J. T., Iadonato, S., Wulff, H., et al. (2012) · Toxicon · doi:10.1016/j.toxicon.2011.07.016 · Cited by 213 · cited 2×
“when these cells are terminally differentiated into effector memory T cells (TEM cells) [17,18,21].”
BackgroundSelf-citationMatheu, M. P., Beeton, C., Garcia, A., Chi, V., Rangaraju, S., Safrina, O., Monaghan, K., Uemura, M. I., Li, D., Pal, S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.015 · Cited by 196 · cited 1×
“6, and shows efficacy in a number of animal models of chronic inflammatory diseases [22,23,30,31].”
BackgroundSelf-citationSolution structure of ShK toxin, a novel potassium channel inhibitor from a sea anemone
Tudor, J. E., Pallaghy, P. K., Pennington, M. W., & Norton, R. S. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0496-317 · Cited by 191 · cited 2×
“We also determined the three-dimensional structure and solution properties of ShK using NMR spectroscopy [12,13].”
BackgroundMethodSelf-citationBeeton, C., Barbaria, J., Giraud, P., Devaux, J., Benoliel, A.-M., Gola, M., Sabatier, J. M., Bernard, D., Crest, M., & Béraud, E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.936 · Cited by 191 · cited 1×
“encephalomyelitis (EAE), an animal model of MS mediated by T lymphocytes [27].”
BackgroundSelf-citationRus, H., Pardo, C. A., Hu, L., Darrah, E., Cudrici, C., Niculescu, T., Niculescu, F., Mullen, K. M., Allie, R., Guo, L., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501770102 · Cited by 184 · cited 1×
“3 channels in these conditions [22–25].”
Self-citationEngineering a Stable and Selective Peptide Blocker of the Kv1.3 Channel in T Lymphocytes
Pennington, M. W., Beeton, C., Galea, C. A., Smith, B. J., Chi, V., Monaghan, K. P., Garcia, A., Rangaraju, S., Giuffrida, A., Plank, D. W., et al. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.052704 · Cited by 138 · cited 2×
“1 and all other tested channels by >100-fold [32].”
BackgroundSelf-citationRauer, H., Pennington, M., Cahalan, M., & Chandy, K. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21885 · Cited by 133 · cited 2×
“We began a systematic study of the peptide by mapping its disulfide bonds [8] and probing its K channel binding using alanine scanning [9–11].”
BackgroundMethodSelf-citationTarcha, E. J., Chi, V., Muñoz-Elías, E. J., Bailey, D., Londono, L. M., Upadhyay, S. K., Norton, K., Banks, A., Tjong, I., Nguyen, H., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.191890 · Cited by 117
Self-citationPotassium Channels, Memory T Cells, and Multiple Sclerosis
Beeton, C., & Chandy, K. G. (2005) · The Neuroscientist · doi:10.1177/1073858405278016 · Cited by 111 · cited 2×
“when these cells are terminally differentiated into effector memory T cells (TEM cells) [17,18,21].”
BackgroundSelf-citationPENNINGTON, M. W., BYRNES, M. E., ZAYDENBERG, I., KHAYTIN, I., DE CHASTONAY, J., KRAFTE, D. S., HILL, R., MAHNIR, V. M., VOLBERG, W. A., GORCZYCA, W., et al. (1995) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1995.tb01068.x · Cited by 104 · cited 1×
“3 channels in Jurkat cells [7].”
Self-citationAnalogs of the Sea Anemone Potassium Channel Blocker ShK for the Treatment of Autoimmune Diseases
Beeton, C., W. Pennington, M., & S. Norton, R. (2011) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152811797200641 · Cited by 98 · cited 2×
“when these cells are terminally differentiated into effector memory T cells (TEM cells) [17,18,21].”
BackgroundSelf-citationVenoms to Drugs: Venom as a Source for the Development of Human Therapeutics
(2015) · RSC drug discovery/RSC drug discovery series · doi:10.1039/9781849737876 · Cited by 98
Rashid, H., Huq, R., Tanner, M. R., Chhabra, S., Khoo, K. K., Estrada, R., Dhawan, V., Chauhan, S. S., Pennington, M. W., Beeton, C., et al. (2014) · Scientific Reports · doi:10.1038/srep04509 · Cited by 87
Self-citationStructures of sea anemone toxins
Norton, R. S. (2009) · Toxicon · doi:10.1016/j.toxicon.2009.02.035 · Cited by 80 · cited 1×
“Within this phylum, the Anthozoa class are found in both fresh water (hydroids) and salt water (sea anemones, jellyfish and corals) environments [1,2].”
BackgroundSelf-citationKem, W. R., & Dunn, B. M. (1988) · Toxicon · doi:10.1016/0041-0101(88)90198-5 · Cited by 78 · cited 1×
“The cytolysins from this animal are approximately 17-kDa proteins with highly basic pI (>9), which cause hemolysis that can be inhibited by preincubation with sphingomyelin [4].”
BackgroundKem, W. R., Parten, B. F., Pennington, M. W., Price, D. A., & Dunn, B. M. (1989) · Biochemistry · doi:10.1021/bi00434a050 · Cited by 76 · cited 1×
“The first ion channel blocking peptide isolated was a Na channel blocker (ShN) composed of 48 residues with three disulfide bonds [5].”
BackgroundSelf-citationRashid, M. H., Heinzelmann, G., Huq, R., Tajhya, R. B., Chang, S. C., Chhabra, S., Pennington, M. W., Beeton, C., Norton, R. S., & Kuyucak, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078712 · Cited by 72 · cited 1×
“1 to gain insight into the molecular basis of the improved selectivity although our recent studies [34,35,38,39] suggest”
Self-citationAn Essential Binding Surface for ShK Toxin Interaction with Rat Brain Potassium Channels
Pennington, M. W., Mahnir, V. M., Khaytin, I., Zaydenberg, I., Byrnes, M., & Kem, W. R. (1996) · Biochemistry · doi:10.1021/bi962463g · Cited by 71 · cited 1×
“The Asp at position 5 is conserved across all of these peptides and has been shown to be critical for proper folding of the peptide as it forms a salt bridge with Lys30 [9,12,13].”
BackgroundSelf-citationBlocking KV1.3 Channels Inhibits Th2 Lymphocyte Function and Treats a Rat Model of Asthma
Koshy, S., Huq, R., Tanner, M. R., Atik, M. A., Porter, P. C., Khan, F. S., Pennington, M. W., Hanania, N. A., Corry, D. B., & Beeton, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517037 · Cited by 66 · cited 1×
“6, and shows efficacy in a number of animal models of chronic inflammatory diseases [22,23,30,31].”
BackgroundSelf-citationPennington, M. W., Mahnir, V. M., Krafte, D. S., Zaydenberg, I., Byrnes, M., Khaytin, I., Crowley, K., & Kem, W. R. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0297 · Cited by 64 · cited 2×
“We began a systematic study of the peptide by mapping its disulfide bonds [8] and probing its K channel binding using alanine scanning [9–11].”
BackgroundMethodSelf-citationPennington, M. W., Rashid, M. H., Tajhya, R. B., Beeton, C., Kuyucak, S., & Norton, R. S. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.09.038 · Cited by 41
Self-citationPohl, J., Hubálek, F., Byrnes, M., Nielsen, K. R., Woods, A. S., & Pennington, M. W. (1995) · Letters in Peptide Science · doi:10.1007/bf00119770 · Cited by 40 · cited 1×
“We began a systematic study of the peptide by mapping its disulfide bonds [8] and probing its K channel binding using alanine scanning [9–11].”
MethodSelf-citationIonisation behaviour and solution properties of the potassium‐channel blocker ShK toxin
Tudor, J. E., Pennington, M. W., & Norton, R. S. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2510133.x · Cited by 38 · cited 2×
“We also determined the three-dimensional structure and solution properties of ShK using NMR spectroscopy [12,13].”
BackgroundMethodSelf-citationMiddleton, R. E., Sánchez, M., Linde, A.-R., Bugianesi, R. M., Dai, G., Felix, J. P., Koprak, S., Staruch, M. J., Bruguera, M., Cox, R., et al. (2003) · Biochemistry · doi:10.1021/bi035209e · Cited by 29 · cited 1×
“3 channel vesicles of 150 fM [16].”
Serdar Kuyucak, B., & Norton, R. S. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.98 · Cited by 29 · cited 1×
“1 to gain insight into the molecular basis of the improved selectivity although our recent studies [34,35,38,39] suggest”
Self-citationChang, S. C., Galea, C. A., Leung, E. W. W., Tajhya, R. B., Beeton, C., Pennington, M. W., & Norton, R. S. (2012) · Toxicon · doi:10.1016/j.toxicon.2012.05.017 · Cited by 22 · cited 3×
“The resulting inclusion bodies were solubilized using buffers containing denaturants followed by on-column refolding by gradual removal of denaturants, as described previously [37].”
MethodInfluentialSelf-citationSCORPION VENOM AND MULTIPLE SCLEROSIS
Breland, A. E., & Currier, R. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90996-0 · Cited by 17 · cited 1×
“Furthermore, medical reports of people with autoimmune diseases documented amelioration of their symptoms following scorpion envenomation, prompting interest in understanding the cause of this effect [26].”
BackgroundInfluential
Research works printed but not linked: 1
- Pennington M.W. Kem W.R. Karlsson E. Sea anemone potassium channel toxins Guidebook to Protein Toxins and Their Use in Cell Biology Montecucco C.A.R. Oxford University Press Oxford, UK 1997 159 161
Cited by
Baell, J. B. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00947 · Cited by 539
Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H. G., & Prinsep, M. R. (2017) · Natural Product Reports · doi:10.1039/c6np00124f · Cited by 465
Rangaraju, S., Dammer, E. B., Raza, S. A., Rathakrishnan, P., Xiao, H., Gao, T., Duong, D. M., Pennington, M. W., Lah, J. J., Seyfried, N. T., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0254-8 · Cited by 430
“ShK-223 peptide was synthesized and folded as previously described [25].”
MethodSelf-citationSea Anemones: Quiet Achievers in the Field of Peptide Toxins
Prentis, P. J., Pavasovic, A., & Norton, R. S. (2018) · Toxins · doi:10.3390/toxins10010036 · Cited by 131
Self-citationCyclic Peptides in Pipeline: What Future for These Great Molecules?
Costa, L., Sousa, E., & Fernandes, C. (2023) · Pharmaceuticals · doi:10.3390/ph16070996 · Cited by 101
Metadata
- Authors
- Pennington, M., Chang, S., Chauhan, S., Huq, R., Tajhya, R., Chhabra, S., Norton, R., & Beeton, C.
- Affiliations
- Peptides International (United States) (US)
- Monash University (AU)
- Baylor College of Medicine (US)
- Corresponding author
- Pennington, Michael
- ORCID
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2015-01-16
- Volume
- 13
- Issue
- 1
- Pages
- 529-542
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC4306950
- OpenAlex
- W2008077937
- Cited by
- 70
- References
- 38
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 6 · 2023: 10 · 2022: 3 · 2021: 9 · 2020: 7 · 2019: 6 · 2018: 5 · 2017: 9 · 2016: 4 · 2015: 3
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- Funders
- NIH (NS073712)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- Kv1.3 potassium channel, Kv1.1, voltage-gated potassium channels, disulfide-rich peptides, peptide analogues, channel selectivity, Kv1.4, Kv1.6, autoimmune disease therapy, Stichodactyla helianthus
- MeSH terms
- Amino Acid Sequence, Animals, Chromatography, High Pressure Liquid, Dose-Response Relationship, Drug, Molecular Sequence Data, Peptides, Sea Anemones, Patch-Clamp Techniques, Inhibitory Concentration 50, Kv1.1 Potassium Channel, Kv1.3 Potassium Channel, Chromatography, Reverse-Phase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.